Jaguar Health, Inc. - Special Call Transcript
Good afternoon. My name is Lisa Conte. I am the founder and CEO of Jaguar Health and our wholly owned subsidiary, Napo Pharmaceuticals, a company committed to novel plant-based prescription drug development. I want to begin by thanking all of you for taking part in our very first Diarrhea Dialogues event.
We've designed the educational event with the key goal of raising awareness among the investor community and global business development context regarding the need for supportive care for people related to chronic, lower gastrointestinal tract distress, specifically the debilitating diarrhea that often results from cancer and cancer therapy, also referred to as cancer therapy related diarrhea, or CTD.
Research shows CTD occurs in up to 80% of cancer patients and is far from a trivial problem. The condition not only has an enormous impact on cancer patients comfort and sensitivity, over 50% of the time diarrhea triggers the need for drug holidays, dose reductions or treatment failure during cancer therapy, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
